nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acidosis overrides molecular heterogeneity to shape therapeutically targetable metabolic phenotypes in colon cancers
|
Richiardone, Elena |
|
|
613 |
C |
p. |
artikel |
2 |
Atovaquone and selinexor as a novel combination treatment option in acute myeloid leukemia
|
Weiss, Stefanie |
|
|
613 |
C |
p. |
artikel |
3 |
ATRX mutations mediate an immunogenic phenotype and macrophage infiltration in neuroblastoma
|
Lorenzi, Federica |
|
|
613 |
C |
p. |
artikel |
4 |
Combined MDM2 and G2/M checkpoint inhibition induces synergistic antitumor response in gastric signet-ring cell carcinoma
|
Luo, Dandong |
|
|
613 |
C |
p. |
artikel |
5 |
Corrigendum to “The long noncoding RNA LUCAT1 promotes tumorigenesis by controlling ubiquitination and stability of DNA methyltransferase 1 in esophageal squamous cell carcinoma” [Cancer Lett. (2018) 47–57]
|
Yoon, Jung-Ho |
|
|
613 |
C |
p. |
artikel |
6 |
Drug resistance in TKI therapy for hepatocellular carcinoma: Mechanisms and strategies
|
Jiang, Xue |
|
|
613 |
C |
p. |
artikel |
7 |
Editorial Board
|
|
|
|
613 |
C |
p. |
artikel |
8 |
Efficient discovery of robust prognostic biomarkers and signatures in solid tumors
|
Liu, Zaoqu |
|
|
613 |
C |
p. |
artikel |
9 |
Exploring the biological mechanism and clinical value of perineural invasion in pancreatic cancer
|
Yuan, Hao |
|
|
613 |
C |
p. |
artikel |
10 |
Harnessing the power of TCR-T cell therapy: A new era in cancer immunotherapy
|
Cai, Yuanting |
|
|
613 |
C |
p. |
artikel |
11 |
Intranuclear TCA and mitochondrial overload: The nascent sprout of tumors metabolism
|
Yuan, Weixi |
|
|
613 |
C |
p. |
artikel |
12 |
Long-term survival case of SCLC transformation after Osimertinib resistance in EGFR-mutant NSCLC: Benefits from chemo-immunotherapy combined with anti-angiogenic therapy followed by Osimertinib rechallenge
|
Liu, Dujiang |
|
|
613 |
C |
p. |
artikel |
13 |
Machine learning-based lactate-related genes signature predicts clinical outcomes and unveils novel therapeutic targets in esophageal squamous cell carcinoma
|
Yu, Chuting |
|
|
613 |
C |
p. |
artikel |
14 |
Metronomic chemotherapy and drug repurposing: Two sides of an oncology coin to reduce host and financial toxicity
|
André, Nicolas |
|
|
613 |
C |
p. |
artikel |
15 |
NEAT1 promotes the perineural invasion of pancreatic cancer via the E2F1/GDNF axis
|
Gu, Jingtao |
|
|
613 |
C |
p. |
artikel |
16 |
Osalmid sensitizes clear cell renal cell carcinoma to navitoclax through a STAT3/BCL-XL pathway
|
Xue, Yizheng |
|
|
613 |
C |
p. |
artikel |
17 |
Phase Ib study of SCT200 combined with paclitaxel or docetaxel in patients with recurrent or metastatic head and neck squamous cell carcinoma following platinum-based chemotherapy and PD-1 antibody
|
Lin, Jinguan |
|
|
613 |
C |
p. |
artikel |
18 |
Phase separation of EEF1E1 promotes tumor stemness via PTEN/AKT-mediated DNA repair in hepatocellular carcinoma
|
Pu, Xiaofan |
|
|
613 |
C |
p. |
artikel |
19 |
REDD1 is a determinant of the sensitivity of renal cell carcinoma cells to autophagy inhibition that can be therapeutically exploited by targeting PIM activity
|
Carew, Jennifer S. |
|
|
613 |
C |
p. |
artikel |
20 |
Synergistic enhancement of radio-immunotherapy efficacy by IL-15 via macrophage activation and memory T cell response
|
Jin, Peng |
|
|
613 |
C |
p. |
artikel |
21 |
Temporal myc dynamics permit mitotic bypass, promoting polyploid phenotypes
|
Loycano, Michael A. |
|
|
613 |
C |
p. |
artikel |
22 |
Tertiary lymphoid structures as a biomarker in immunotherapy and beyond: Advancing towards clinical application
|
Cui, Xinyu |
|
|
613 |
C |
p. |
artikel |
23 |
The YTHDF3-DT/miR-301a-3p /INHBA axis attenuates autophagy-dependent ferroptosis in lung adenocarcinoma
|
Peng, Xiong |
|
|
613 |
C |
p. |
artikel |
24 |
ZNF251 haploinsufficiency confers PARP inhibitors resistance in BRCA1-mutated cancer cells through activation of homologous recombination
|
Li, Huan |
|
|
613 |
C |
p. |
artikel |